Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 400

1.

Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.

Chivukula M, Haynik DM, Brufsky A, Carter G, Dabbs DJ.

Am J Surg Pathol. 2008 Nov;32(11):1721-6. doi: 10.1097/PAS.0b013e31817dc3a6.

PMID:
18769331
2.
3.

Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity.

Reis-Filho JS, Simpson PT, Jones C, Steele D, Mackay A, Iravani M, Fenwick K, Valgeirsson H, Lambros M, Ashworth A, Palacios J, Schmitt F, Lakhani SR.

J Pathol. 2005 Sep;207(1):1-13.

PMID:
15957152
5.

Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases.

Fadare O, Dadmanesh F, Alvarado-Cabrero I, Snyder R, Stephen Mitchell J, Tot T, Wang SA, Ghofrani M, Eusebi V, Martel M, Tavassoli FA.

Am J Surg Pathol. 2006 Nov;30(11):1445-53.

PMID:
17063087
6.

The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?

Fadare O, Wang SA, Hileeto D.

Hum Pathol. 2008 Mar;39(3):331-6. doi: 10.1016/j.humpath.2007.07.014.

PMID:
18261623
7.

Invasive lobular carcinoma: to grade or not to grade.

Bane AL, Tjan S, Parkes RK, Andrulis I, O'Malley FP.

Mod Pathol. 2005 May;18(5):621-8.

8.

Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.

Ariga R, Zarif A, Korasick J, Reddy V, Siziopikou K, Gattuso P.

Breast J. 2005 Jul-Aug;11(4):278-80.

PMID:
15982396
10.

Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?

Middleton LP, Grant S, Stephens T, Stelling CB, Sneige N, Sahin AA.

Mod Pathol. 2003 Feb;16(2):120-9.

11.

Multicentric mammary carcinoma: evidence of monoclonal proliferation.

Middleton LP, Vlastos G, Mirza NQ, Eva S, Sahin AA.

Cancer. 2002 Apr 1;94(7):1910-6.

12.

Invasive pleomorphic lobular carcinoma, negative for ER, PR and Her/2neu--a case report.

Manucha V, Khilko N, Reilly K, Zhang X.

Int J Clin Exp Pathol. 2011 Jan 30;4(2):200-5.

13.
14.
15.

Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis.

Middleton LP, Palacios DM, Bryant BR, Krebs P, Otis CN, Merino MJ.

Am J Surg Pathol. 2000 Dec;24(12):1650-6.

PMID:
11117786
16.

E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast.

Mastracci TL, Tjan S, Bane AL, O'Malley FP, Andrulis IL.

Mod Pathol. 2005 Jun;18(6):741-51.

18.

E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma.

Wahed A, Connelly J, Reese T.

Ann Diagn Pathol. 2002 Dec;6(6):349-51.

PMID:
12478484
19.

Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin.

Dabbs DJ, Bhargava R, Chivukula M.

Am J Surg Pathol. 2007 Mar;31(3):427-37.

PMID:
17325485
20.

Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis.

Carder PJ, Shaaban A, Alizadeh Y, Kumarasuwamy V, Liston JC, Sharma N.

Histopathology. 2010 Sep;57(3):472-8. doi: 10.1111/j.1365-2559.2010.03634.x. Epub 2010 Aug 19.

PMID:
20727019

Supplemental Content

Support Center